The FDA has published draft guidance for software assurance in an attempt to improve patient safety. They recommend a “risk-based approach to establish confidence in the automation used for production or quality systems.” The FDA is encouraging medical device manufacturers to not only leverage the advancement of technology to improve efficiency, but also improve quality.

Read the draft guidance here.